ASRIX | MGLIX | ASRIX / MGLIX | |
Total Expense Ratio | 0.91 | 0.94 | 97% |
Annual Report Gross Expense Ratio | 0.91 | 0.95 | 96% |
Fund Existence | 18 years | 16 years | - |
Gain YTD | 4.002 | 2.494 | 160% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 366M | 2.29B | 16% |
Annual Yield % from dividends | 3.83 | 2.53 | 151% |
Returns for 1 year | 4.78 | 3.42 | 140% |
Returns for 3 years | 2.28 | -9.29 | -25% |
Returns for 5 years | 16.80 | 11.20 | 150% |
Returns for 10 years | 26.87 | 32.20 | 83% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MAGCX | 27.90 | N/A | N/A |
BlackRock Advantage Global Institutional | |||
JFNAX | 63.85 | N/A | N/A |
Janus Henderson Global Life Sciences A | |||
UIVAX | 18.90 | N/A | N/A |
Victory Value Institutional | |||
AMIDX | 13.31 | N/A | N/A |
Amana Developing World Institutional | |||
RYAZX | 183.24 | N/A | N/A |
Rydex S&P SmallCap 600 Pure Value H |